Aetna International is set to take over Aviva UK’s IPMI division

By Catherine Sturman
Share
Leading global health care benefits provider, Aetna International has entered an agreement to acquire Aviva UK’s International Private Medical Insuran...

Leading global health care benefits provider, Aetna International has entered an agreement to acquire Aviva UK’s International Private Medical Insurance (IPMI) operations. From May 2018, Aviva UK will no longer provide IPMI cover for new customers or for existing customers wishing to renew their policies. 

Serving over 700,000 million members worldwide, Aetna International offers a multitude of services, delivering comprehensive health care benefits, alongside customised technological and health management solutions, covering health care systems, government entities and large employers.

Under the agreement, existing Aviva IPMI customers will be offered continuation terms at policy renewal with Aetna International. Existing Aviva customers who renew their policy will then become Aetna customers and will no longer have a relationship with Aviva.

See also

David Healy, CEO EMEA at Aetna International said: “We are delighted to have reached this agreement with Aviva. 

We are committed to delivering Aviva’s IPMI customers continuation of cover with Aetna that provides comparable benefits and an excellent level of service. This is very much in line with our business strategy to deliver comprehensive health care benefits worldwide.

Our scale, expertise, customer service infrastructure and technological focus in IPMI allow us to make a significant contribution to improving people’s health and the quality of care they receive.”

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare